Quarterly Period Covered: First quarter of fiscal year 2026 (October 1 - December 31, 2025), filed February 3, 2026 Company Information: Emerson Electric Co., a Missouri-incorporated manufacturer of electronic and electrical equipment (excluding computer equipment), headquartered in St. Louis, MO; trades on NYSE under ticker EMR Financial Statements Included: Consolidated balance sheet as of…

Our analysis rates this filing CAUTIOUS. The elevated concern level of 6.8/10 reflects a company navigating significant near-term execution risks from dual major acquisitions while simultaneously managing an active restructuring program. The National Instruments acquisition in Q1 FY2026 represents a…

Concern level: HIGH (6.8/10). Key factors: National Instruments acquisition (Q1 FY2026) represents high-severity integration risk (severity 7/10) with potential for goodwill impairment if synergies not realized; Compounded acquisition execution risk from two major deals in rapid succession: AspenTech (March 2025) and National Instruments (Q1 FY2026), creating material near-term integration…

Notable risk changes: National Instruments acquisition completed in Q1 FY2026 - major software/test & measurement consolidation creating near-term integration execution risk and potential for goodwill impairment if synergies not achieved; Active restructuring program underway with employee severance and other restructuring reserves, indicating management is taking action but creating execution risk and potential for…

The model predicts EMR will underperform the S&P 500 by about 0.0% over 30 days (model confidence 50%). This is model analysis for research, not investment advice.